Systane Clinical Experience Study

Study to Evaluate the Physical Effect of SYSTANE QID in People That Have Moderate to Severe Dry Feeling Eyes

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00818909

Enrollment

941

Registered

2009-01-08

Start date

2009-01-31

Completion date

2009-10-31

Last updated

2012-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndrome

Keywords

Dry eye, Systane, Moderate to severe dry eye

Brief summary

To evaluate the physical effect of SYSTANE QID in people that have moderate to severe dry eyes and to establish doctor confidence to prescribe Systane.

Interventions

OTHERSystane

Systane prescription

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* moderate to severe dry feeling eyes

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
corneal and conjunctiva staining score	4 weeks

Secondary

Measure	Time frame
Tear film break up time	4 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026